See How The Body's Intrinsic Cannabinoids Work

Endocannabinoids serve as a natural check on the nervous system.1
Learn how they help the body maintain homeostasis.

WATCH

Cannabinoids break down into 3 main classes:
endocannabinoids, phytocannabinoids, and synthetic cannabinoids.1, 2

Endocannabinoids are chemicals produced inside of your body that attach to the same receptors as some phytocannabinoids.

Endocannabinoids

Phyto-, meaning plant, cannabinoids are chemicals found in and extracted from the cannabis plant.

Phytocannabinoids

Synthetic cannabinoids are chemicals made in a laboratory to mimic phytocannabinoids, which are chemicals found naturally in the cannabis plant

Synthetic Cannabinoids

The Effects of Naturally-occurring Cannabinoids

Cannabis sativa L. is a species of flowering plants in the Cannabaceae family. It has been used therapeutically for thousands of years, while also being notorious for its “high”-inducing psychotropic effects. But now with the discovery of cannabinoids, we are able to better understand the cause of these effects.38, 39

An orange, thumbnail size image of a graduation cap

Test your knowledge

THC and CBD are 2 different cannabinoids that both cause the high that is commonly associated with marijuana.

1. VanDolah HJ, Bauer BA, Mauck KF. Clinicians' Guide to Cannabidiol and Hemp Oils. Mayo Clin Proc. Sep 2019;94(9):1840-1851. doi:10.1016/j.mayocp.2019.01.003

2. Alger BE. Getting high on the endocannabinoid system. Cerebrum. Nov 2013;2013:14.

3. Mackie K. Cannabinoid receptors: where they are and what they do. J Neuroendocrinol. May 2008;20 Suppl 1:10-4. doi:10.1111/j.1365-2826.2008.01671.x

4. Rosenberg EC, Tsien RW, Whalley BJ, Devinsky O. Cannabinoids and Epilepsy. Neurotherapeutics. Oct 2015;12(4):747-68. doi:10.1007/s13311-015-0375-5

5. Maccarrone M, Bab I, Biro T, et al. Endocannabinoid signaling at the periphery: 50 years after THC. Trends Pharmacol Sci. May 2015;36(5):277-96. doi:10.1016/j.tips.2015.02.008

6. Flores-Sanchez IJ, Verpoorte R. Secondary metabolism in cannabis. Phytochemistry Reviews. 2008;7(3):615-639. doi:10.1007/s11101-008-9094-4

7. US Food and Drug Administration. FDA and Cannabis: Research and Drug Approval Process. Updated Oct 10, 2020. Accessed Sept 2, 2021. https://www.fda.gov/news-events/public-health-focus/fda-and-cannabis-research-and-drug-approval-process

8. Epidiolex® (cannabidiol) oral solution [prescribing information]. Carlsbad, CA: Jazz Pharmaceuticals, Inc. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8bf27097-4870-43fb-94f0-f3d0871d1eec

9. Yang Y, Lewis MM, Bello AM, Wasilewski E, Clarke HA, Kotra LP. Cannabis sativa (Hemp) Seeds, Delta(9)-Tetrahydrocannabinol, and Potential Overdose. Cannabis Cannabinoid Res. 2017;2(1):274-281. doi:10.1089/can.2017.0040

10. Small E. Evolution and Classification of Cannabis sativa (Marijuana, Hemp) in Relation to Human Utilization. Bot Rev. Sept 1 2015;81(3):189-294. doi:10.1007/s12229-015-9157-3

11. House of Representatives. (2018) Agriculture Improvement Act of 2018. https://www.congress.gov/bill/115th-congress/house-bill/2/text

12. House of Representatives. (2025) Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026. https://www.congress.gov/bill/119th-congress/house-bill/5371/text/eas

13. Flores RM. Co-Produced Water Management and Environmental Impacts. In: Flores RM, ed. Coal and Coalbed Gas. Elsevier; 2014:437-508.

14. Husain R, Weeden H, Bogush D, et al. Enhanced tolerance of industrial hemp (Cannabis sativa L.) plants on abandoned mine land soil leads to overexpression of cannabinoids. PLoS One. 2019;14(8):e0221570. doi:10.1371/journal.pone.0221570

15. McPartland JM, McKernan KJ. Contaminants of Concern in Cannabis: Microbes, Heavy Metals and Pesticides. In: Chandra S, Lata H, ElSohly MA, eds. Cannabis sativa L - Botany and Biotechnology. Springer International Publishing; 2017:457-474:chap 22.

16. Sarma ND, Waye A, ElSohly MA, et al. Cannabis Inflorescence for Medical Purposes: USP Considerations for Quality Attributes. J Nat Prod. Apr 24 2020;83(4):1334-1351. doi:10.1021/acs.jnatprod.9b01200

17. Kocis PT, Vrana KE. Delta-9-Tetrahydrocannabinol and Cannabidiol Drug-Drug Interactions. Med Cannabis Cannabinoids. Aug 2020;3(1):61-73. doi:10.1159/000507998

18. Witek TJ, Jr. Please don't call it medical marijuana unless it is; but it probably isn't. Can J Public Health. Feb 2021;112(1):74-77. doi:10.17269/s41997-020-00333-2

19. Marijuana Policy Project. “Prescribing” Versus “Recommending" Medical Cannabis. Accessed Dec 3, 2021. https://www.mpp.org/issues/medical-marijuana/prescribing-versus-recommending-medical-cannabis/

20. National Conference of State Legislatures. State medical marijuana laws. 2025. Accessed Mar 25, 2025. https://www.ncsl.org/health/state-medical-cannabis-laws

21. Bonn-Miller MO, Loflin MJE, Thomas BF, Marcu JP, Hyke T, Vandrey R. Labeling Accuracy of Cannabidiol Extracts Sold Online. JAMA. Nov 7 2017;318(17):1708-1709. doi:10.1001/jama.2017.11909

22. Vandrey R, Raber JC, Raber ME, Douglass B, Miller C, Bonn-Miller MO. Cannabinoid Dose and Label Accuracy in Edible Medical Cannabis Products. JAMA. Jun 23-30 2015;313(24):2491-3. doi:10.1001/jama.2015.6613

23. US Food and Drug Administration. Warning Letters and Test Results for Cannabidiol-Related Products. FDA.gov. Updated Sept 3, 2025, 2025. Accessed Feb 21, 2025. https://www.fda.gov/news-events/public-health-focus/warning-letters-and-test-results-cannabidiol-related-products

24. Tai S, Fantegrossi WE. Synthetic Cannabinoids: Pharmacology, Behavioral Effects, and Abuse Potential. Curr Addict Rep. Jun 1 2014;1(2):129-136. doi:10.1007/s40429-014-0014-y

25. Marinol® (dronabinol) capsules, for oral use [prescribing information]. North Chicago, IL: AbbVie Inc. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=d0efeeec-640d-43c3-8f0a-d31324a11c68

26. Syndros® (dronabinol) oral solution [prescribing information]. Chandler, AZ: Benuvia Therapeutics Inc. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a7801c70-995d-46a2-91ee-141ef427c6b5

27. Cesamet® (nabilone) capsules [prescribing information]. Bridgewater, NJ: Bausch Health US LLC. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=83c7ac15-ece9-47de-b83c-d575544fa449

28. National Institute on Drug Abuse. What are synthetic cannabinoids? 2023. Accessed Mar 24, 2025. https://www.drugabuse.gov/publications/drugfacts/synthetic-cannabinoids-k2spice

29. Centers for Disease Control and Prevention. Cannabis Frequently Asked Questions. 2025. Accessed Mar 24, 2025. https://www.cdc.gov/cannabis/faq/index.html

30. Ruthirakuhan M, Herrmann N, Andreazza AC, et al. Agitation, Oxidative Stress, and Cytokines in Alzheimer Disease: Biomarker Analyses From a Clinical Trial With Nabilone for Agitation. J Geriatr Psychiatry Neurol. Jul 2020;33(4):175-184. doi:10.1177/0891988719874118

31. Peball M, Werkmann M, Ellmerer P, et al. Nabilone for non-motor symptoms of Parkinson's disease: a randomized placebo-controlled, double-blind, parallel-group, enriched enrolment randomized withdrawal study (The NMS-Nab Study). J Neural Transm (Vienna). Aug 2019;126(8):1061-1072. doi:10.1007/s00702-019-02021-z

32. Nabilone for Non-motor Symptoms in Parkinson's Disease (NMS-Nab). ClinicalTrials.gov Identifier: NCT03769896. Updated Mar 2, 2021. Accessed Dec 6, 2021. https://clinicaltrials.gov/ct2/show/results/NCT03769896

33. Mascal M, Hafezi N, Wang D, et al. Synthetic, non-intoxicating 8,9-dihydrocannabidiol for the mitigation of seizures. Sci Rep. May 23 2019;9(1):7778. doi:10.1038/s41598-019-44056-y

34. ClinicalTrials.gov. Dronabinol Trials. Accessed Feb 25, 2026. https://clinicaltrials.gov/ct2/results?cond=&term=Dronabinol

35. ClinicalTrials.gov. Nabilone Trials. Accessed Feb 25, 2026. https://clinicaltrials.gov/ct2/results?cond=&term=Nabilone

36. Sholler DJ, Huestis MA, Amendolara B, Vandrey R, Cooper ZD. Therapeutic potential and safety considerations for the clinical use of synthetic cannabinoids. Pharmacol Biochem Behav. 2020;199:173059-173059. doi:10.1016/j.pbb.2020.173059

37. United Nations Office on Drugs and Crime. Synthetic cannabinoids. Accessed Mar 1, 2026. https://www.unodc.org/LSS/SubstanceGroup/Details/ae45ce06-6d33-4f5f-916a-e873f07bde02

38. ElSohly M, Gul W. Constituents of Cannabis sativa. In: Pertwee R, ed. Handbook of Cannabis. Oxford University Press; 2014:3-22:chap 1.

39. Fischedick JT, Hazekamp A, Erkelens T, Choi YH, Verpoorte R. Metabolic fingerprinting of Cannabis sativa L., cannabinoids and terpenoids for chemotaxonomic and drug standardization purposes. Phytochemistry. Dec 2010;71(17-18):2058-73. doi:10.1016/j.phytochem.2010.10.001